3,4-methylenedioxyamphetamine and methysergide

3,4-methylenedioxyamphetamine has been researched along with methysergide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boja, JW; Crisp, T; Schechter, MD; Stafinsky, JL1
Gold, LH; Koob, GF1
Colado, MI; Elliott, JM; Esteban, B; Green, AR; Mechan, AO; O'Shea, E1

Other Studies

3 other study(ies) available for 3,4-methylenedioxyamphetamine and methysergide

ArticleYear
The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA) in the rat.
    Pharmacology, biochemistry, and behavior, 1989, Volume: 34, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Analgesics; Animals; Dose-Response Relationship, Drug; Male; Methysergide; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Pain; Rats; Rats, Inbred Strains; Receptors, Serotonin

1989
Methysergide potentiates the hyperactivity produced by MDMA in rats.
    Pharmacology, biochemistry, and behavior, 1988, Volume: 29, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Drug Synergism; Male; Methysergide; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Receptors, Serotonin

1988
The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
    British journal of pharmacology, 2002, Volume: 135, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Acute Disease; Animals; Benzazepines; Body Temperature; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Fever; Hallucinogens; Hippocampus; Male; Methysergide; N-Methyl-3,4-methylenedioxyamphetamine; Neuroprotective Agents; Piperazines; Piperidines; Rats; Rats, Inbred Strains; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Remoxipride; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists

2002